Furthermore, in addition to impacting endothelial cells and curtailing the production of matrix metalloproteinase-2 (MMP-2), methylated selenium has also been shown to inhibit vascular endothelial growth factor (VEGF) expression in breast cancer cells (57). The gene discussed is VEGFA; the disease is breast carcinoma.